Otsuka Toshikazu, Fukuyama Takashi, Futawatari Nobue, Tahara Kumiko, Watanabe Masaaki, Ichiki Yoshinobu, Soeno Takafumi, Takahashi Yoshihito, Yamazaki Hitoshi, Fujimori Yuma, Ohshiro Taichi, Kobayashi Noritada, Kida Mitsuhiro, Koizumi Wasaburo, Kusano Chika
Division of Internal Medicine, Kitasato University Medical Centre, Kitamoto, Saitama, Japan.
Division of Biomedical Research, Kitasato University Medical Centre, Kitamoto, Saitama, Japan.
J Cancer. 2022 Oct 31;13(14):3526-3532. doi: 10.7150/jca.67534. eCollection 2022.
Kita-Kyushu lung cancer antigen-1 (KK-LC-1), encoded by , is a cancer/testis antigen (CTA) and an attractive target for immunotherapy. Our previous study demonstrated frequent expression in gastric cancers (GCs) and non-tumor sites of the stomach with tumors. Additionally, there was a correlation with () infection. Since it currently remains unclear whether KK-LC-1 is expressed in the stomach without GC, this study investigated KK-LC-1 expression in non-GC stomach. We investigated differences in gene expression at non-tumor sites of stomachs with or without tumors in 118 GC patients and 115 non-GC patients. Fisher's exact test was used for statistical analyses. expression was detected in 77% of non-tumor sites in stomachs with tumors, which was significantly higher than in stomachs without tumors (7%, p < 0.0001). All patients with expression at non-tumor sites of their stomachs without tumors carried . appears to be rarely expressed in the atrophic stomach, and furthermore, a part of patients positive for its expression will develop GC in the future, suggesting that expression is a useful marker for predicting GC.
北九州肺癌抗原-1(KK-LC-1)由 编码,是一种癌胚抗原(CTA),也是免疫治疗的一个有吸引力的靶点。我们之前的研究表明,KK-LC-1在胃癌(GC)以及伴有肿瘤的胃的非肿瘤部位频繁表达。此外,它与 ()感染存在相关性。由于目前尚不清楚KK-LC-1在无GC的胃中是否表达,本研究调查了其在非GC胃中的表达情况。我们调查了118例GC患者和115例非GC患者有肿瘤或无肿瘤的胃的非肿瘤部位的 基因表达差异。采用Fisher精确检验进行统计分析。在有肿瘤的胃的非肿瘤部位,77%检测到KK-LC-1表达,这显著高于无肿瘤的胃(7%,p<0.0001)。所有在无肿瘤的胃的非肿瘤部位表达KK-LC-1的患者均携带 。KK-LC-1似乎在萎缩性胃中很少表达,此外,其表达呈阳性的部分患者未来会发展为GC,这表明KK-LC-1表达是预测GC的一个有用标志物。